Go to main content
Universitat Autònoma de Barcelona
Institutional Biosafety Committee

News

All the news

  • New edition of the course "Strategies in Biosafety and Biocontainment"

    13 05 2025

    The registration period for the Postgraduate Course "Strategies in Biosafety and Biocontainment" (14th edition). This course, organized by the Faculties of Biosciences and Veterinary Medicine, has the collaboration of IBC-UAB, IRTA-CReSA, CRAG and Hospital Clínic de Barcelona and is preferably aimed at technicians, lab managers, graduates and professionals in the biomedical, biotechnology, veterinary and agri-food sectors.

    training course Strategies in Biosafety and Biocontainment
  • Klotho: a protein that promotes healthy aging and improves longevity

    13 05 2025

    An international study led by the Institut de Neurociències at the UAB (INc-UAB) has shown that increasing levels of the Klotho protein in mice extends lifespan and improves both physical and cognitive health when aging.

    group M Chillon
  • Common lung bacteria team up to evade immune defences

    12 05 2025

    A study led by the UAB and the IBEC has uncovered how co-infection by Pseudomonas aeruginosa and Mycobacterium abscessus, two common lung pathogens, can suppress immune responses and worsen outcomes in patients with respiratory diseases. The findings, published today in the journal Virulence, provide new insight into why polymicrobial infections are particularly difficult to treat and open the door to new therapeutic strategies.

    plate with colonies
  • New Asian wasp queen trapping campaign

    21 03 2025

    The Department of Animal Biology, Plant Biology and Ecology has initiated a new campaign to detect and capture Asian wasp queens on campus. The campaign will last until the end of May.

    asian hornets traps
  • Tough spring forecast for allergy sufferers

    13 03 2025

    UAB researcher Jordina Belmonte, head of the Aerobiological Network of Catalonia (XAC) of ICTA-UAB and BABVE, together with Gaspar Dalmau, physician specialising in allergology and president of the Catalan Society of Allergology and Clinical Immunology (SCAIC), presented the forecast of allergenic pollen levels for this spring and the effects they will have on allergy sufferers.

    pollen measuring equipment
  • The UAB disables its account on the social network X

    26 02 2025

    The presence of the UAB in any of the social networks or communication channels of which it makes use does not in any way presuppose sharing the editorial line or other information contained in these networks or channels.

    logo UAB
  • Two cancer research projects of the UAB receive funding from the AECC

    26 02 2025

    UAB researchers Maria Lluch and Clàudia Faúndez will receive funding from the scientific foundation Associació Espanyola Contra el Càncer (AECC) to develop two projects on glioblastoma and endometrial cancer treatments.

    funding AECC
  • Tetanus Diphtheria Vaccine campaign for those over 40

    02 12 2024

    The vaccination campaign organised by the UAB Healthcare Service will offer the Tetanus Diphtheria Vaccine to university community member aged over 40.

    syringe loading
  • Project to identify new therapies for Alzheimer's disease receives funding from the Alzheimer's Association

    12 11 2024

    The Alzheimer’s Association will fund UAB projects studying the molecular alterations of inhibitory neurons which take place in patients with Alzheimer's.

    grup Arnaldo Parra
  • Nanoparticles designed to trap and neutralise large amounts of SARS-CoV2

    12 11 2024

    Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV-2 virus particles, both in liquid solutions and on the surface of materials. These novel nanoparticles could be used to manufacture antiviral materials such as wastewater and air filters, and could be exploited to develop new tests for the early detection of COVID-19. Moreover, the nanoparticles could be redesigned to target other pathogens.

    design nanoparticles that capture SARS-CoV2 virus